Xeris Pharmaceuticals | XERS - Lieferungen Und Leistungen





Lieferungen Und Leistungen Veränderung Datum
Celltrion KRW 88.58B 9.9B 2026-03
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 6.39M 1.12M 2026-06
Divis Laboratories Ltd INR 12.11B 1.71B 2026-03
Eli Lilly USD 6.11B 1.08B 2026-06
Kangmei Pharma CNY 2.46B 153.5M 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Nektar Therapeutics USD 10.03M 744K 2026-03
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Organigram Holdings CAD 73.14M 2.06M 2026-03
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pacira USD 17.51M 3.5M 2026-06
Perrigo USD 400.4M 34.4M 2026-06
Pharma Mar EUR 38.93M 4.9M 2026-06
Qiagen NV USD 79.08M 785K 2026-06
Sartorius EUR 329.1M 16.2M 2026-06
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Supernus Pharmaceuticals USD 5.59M 4.58M 2026-06
Tilray USD 114.5M 3.69M 2025-09
Zealand Pharma A/S 171M 175.6M 2026-03
Zz Pientze Pharmaceu CNY 471.72M 14.67M 2026-06